The SARS-CoV2 effect on renal function in patients after recovery from COVID-19

Authors

  • Al-abid Naeel Mustafa Mohammed University of Samarra, College of Applied sciences, Department of pathological analysis, Iraq Author
  • Abd-alwahab Wijdan I. A. University of Samarra, College of Education, Department of Biology, Iraq Author
  • Albany ousif Abdullah Medical Laboratory Technology, College of Health and Medical Techniques, Duhok Polytechnic University, Duhok, Iraq. Author
  • Al-Berfkani Mohammad Ismail Medical Laboratory Technology, College of Health and Medical Techniques, Duhok Polytechnic University, Duhok, Iraq.Medical Laboratory Technology, College of Health and Medical Techniques, Duhok Polytechnic University, Duhok, Iraq. Author

Keywords:

COVID-19, Creatinine, Renal, SARS-CoV-2, Urea.

Abstract

Objective: SARS-CoV-2 infects the kidneys through Angiotensin Converting Enzyme 2 (ACE2), which is overexpressed in comparison to some other organs. Thus, leads imbalance of renal function. Methods:
his study involved four groups (G1: Healthy group, G2:Cardiovascular illness group, G3: Respiratory illness group, And G4: recovery from COVID-19 group). Collected blood samples from the COVID-19 epidemic center in Salah Al-din general hospital, with confirmed recovery from COVID-19. Results: The findings of this study demonstrated a significant difference in urea and creatinine concentrations in the G2 and G3 groups compared to the Healthy group in both genders. But the no statistical significance between G4 and Healthy group. and the other hand found a low significance in the concentration of potassium  in  G2,  and  G3  compared  with  the Healthy  group in  both  genders. While  showing  a  high significance in the concentration of potassium in the G4 compared with the Healthy group in males, but no significance in G4 in females. Conclusion: The renal disorders in patients after recovery from COVID-19, can lead to renal damage and impaired function. Maybe the reason is due to the SARS-CoV2 effect on renal epithelial cells and proximal tubule damage.

Downloads

Download data is not yet available.

References

Cheng, Y., Luo, R., Wang, K., Zhang, M.,

Wang, Z., Dong, L., and Xu, G. (2020).

Kidney disease is associated with in-

hospital death of patients with COVID-

Kidney international, 97(5), 829-838.

Post, A., den Deurwaarder, E. S., Bakker, S. J., de

Haas, R. J., van Meurs, M., Gansevoort, R. T.,

and Berger, S. P. (2020). Kidney infarction in

patients with COVID-19. American Journal of

Kidney Diseases, 76(3), 431-435.

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F.

K., Zheng, Q., Meredith, H. R., and

Lessler, J. (2020). The incubation period

of coronavirus disease 2019 (COVID-19)

from publicly reported confirmed cases:

estimation and application. Annals of

internal medicine, 172(9), 577-582.

Liu, Y. M., Xie, J., Chen, M. M., Zhang, X.,

Cheng, X., Li, H., and Li, H. (2021). Kidney

function indicators predict adverse outcomes

of COVID-19. Med, 2(1), 38-48.

Wang, M., Xiong, H., Chen, H., Li, Q., and

Ruan, X. Z. (2021). Renal injury by

SARS-CoV-2 infection: a systematic

review. Kidney Diseases, 7(2), 100-110.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao,

J., Hu, Y., and Cao, B. (2020). Clinical

features of patients infected with 2019

novel coronavirus in Wuhan, China. The

lancet, 395(10223), 497-506.

Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma,

P., Shah, H. H., Barnett, R. L., and

Northwell COVID-19 Research

Consortium. (2020). Acute kidney injury

in patients hospitalized with COVID-

Kidney international, 98(1), 209-218.

Hong, X. W., Chi, Z. P., Liu, G. Y., Huang, H.,

Guo, S. Q., Fan, J. R., and Zhang, Y. H. (2020).

Characteristics of renal function in patients

diagnosed with COVID-19: an observational

study. Frontiers in medicine, 7, 409.

Pranata, R., Soeroto, A. Y., Huang, I., Lim, M.

A., Santoso, P., Permana, H., and Lukito, A.

A. (2020). Effect of chronic obstructive

pulmonary disease and smoking on the

outcome of COVID-19. The International

Journal of Tuberculosis and Lung

Disease, 24(8), 838-843.

Pranata, R., Supriyadi, R., Huang, I.,

Permana, H., Lim, M. A., Yonas, E., andLukito, A. A. (2020). The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-

analysis. Clinical Medicine Insights:

Circulatory, Respiratory and Pulmonary Medicine, 14, 1179548420959165.

Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao,

W., Jiang, W., and Zhang, S. (2020).

Coagulopathy and antiphospholipid

antibodies in patients with Covid-19. New

England Journal of Medicine, 382(17), e38.

Wang, Q., Zhang, Y., Wu, L., Niu, S., Song,

C., Zhang, Z., and Qi, J. (2020).

Structural and functional basis of SARS-

CoV-2 entry by using human

ACE2. Cell, 181(4), 894-904.

Tezcan, M. E., Gokce, G. D., Sen, N.,

Kaymak, N. Z., and Ozer, R. S. (2020).

Baseline electrolyte abnormalities would

be related to poor prognosis in hospitalized

coronavirus disease 2019 patients. New

Microbes and New Infections, 37, 100753.

Chen, D., Li, X., Song, Q., Hu, C., Su, F.,

Dai, J., and Zhang, X. (2020).

Hypokalemia and clinical implications in

patients with coronavirus disease 2019

(COVID-19). MedRxiv.

Downloads

Published

2023-02-28

Issue

Section

Articles

How to Cite

Naeel Mustafa Mohammed , A.- abid, Wijdan I. A. , A.- alwahab, ousif Abdullah , A., & Mohammad Ismail , A.-B. (2023). The SARS-CoV2 effect on renal function in patients after recovery from COVID-19. History of Medicine, 9(1). http://13.200.237.241/HOM/index.php/medicine/article/view/542